Helping Ivoirians stay healthy since the 1980s.
- Jhpiego deployed an electronic platform for monitoring HIV-positive patients on antiretroviral therapy (ART) to help track patients and reduce those who are lost to follow-up or who are being treated at multiple health facilities. This platform was deployed in 170 sites across 27 health regions and 59 health districts, with 158,816 clients on ART registered in the platform. About 95% of these patients were retained in care and 94% were virally suppressed, contributing to the country’s UNAIDS 95-95-95 goals.
- Jhpiego introduced cervical cancer screening for HIV-positive women using visual inspection with acetic acid coupled with immediate treatment (if needed) via cryotherapy. After scaling up this program and successfully handing it over to the government in 2015, Jhpiego began working to introduce the HPV vaccine and HPV self-testing.
- With the Ministry of Health and Ministry of Education, Jhpiego built the capacity of vaccinators, facilitated the accessibility of vaccinations in schools, and coordinated the introduction of vaccinating 9-year-old girls against HPV in all health districts nationwide.
- The MOMENTUM Country and Global Leadership project works on integrated health care with eight ministry directorates and programs, 14 regions and 48 districts. The project has improved availability and application of guidelines and training materials on maternal, newborn and child health and family planning and community-based interventions in integrated intervention areas, including maternal and newborn health, family planning and malaria in pregnancy. The project also revitalized the national technical working groups on malaria prevention in pregnant women and children 0–5 years and maternal and child health.
Our Work in Côte d’Ivoire
MOMENTUM Country and Global Leadership
Moving Integrated, Quality Maternal, Newborn and Child Health and Family Planning and Reproductive Health Services to Scale (MOMENTUM) is a suite of projects, funded by the U.S. Agency for International Development, that aims to accelerate reductions in maternal, newborn and child mortality and morbidity in high-burden countries by increasing host country commitment and capacity to provide high-quality, integrated health care. Each of the projects has a specific focus area; together they provide a comprehensive, flexible package of support for countries as they overcome context-specific health challenges towards sustainable development. The five-year, Jhpiego-led MOMENTUM Country and Global Leadership project focuses on: 1) providing targeted technical and capacity development assistance to our missions, partner countries and local organizations; and 2) contributing to global technical leadership and policy dialogue for improved maternal, newborn and child health, voluntary family planning and reproductive health outcomes. Jhpiego’s 12 sub-partners under this project are: Save the Children, Johns Hopkins University International Vaccine Access Center, The Manoff Group, Quicksand, Matchboxology, BAO Systems, Avenir Health, McKinsey and Company, PACT, Institute for Healthcare Improvement, Christian Connections for International Health and Ubora Quality Institute.
Reaching Impact, Saturation, and Epidemic Control (RISE)
RISE is a five-year global project funded by the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) and the U.S. Agency for International Development (USAID). RISE works with countries to achieve a shared vision of attaining and maintaining epidemic control, with stronger local partners capable of managing and achieving results through sustainable, self-reliant and resilient health systems by 2024. RISE’s contributions to this work will lead to fewer new HIV infections, decreased HIV-related morbidity and mortality, and increased quality of life for people living with HIV. With USAID PEPFAR investments, RISE supports countries to achieve and maintain epidemic control by providing strategic technical assistance and direct service delivery to improve HIV prevention, case finding, treatment programming and viral load suppression. The primary objectives of the RISE project are to: 1) attain and maintain HIV epidemic control among at-risk adult men, women and priority populations; 2) attain and maintain HIV epidemic control among key populations; 3) strengthen health systems including improved program management, health information systems, human resources for health and financial systems to ensure attainment and maintenance of epidemic control; and 4) support the transition of direct funding and implementation to capable local partners to meet the PEPFAR goal of 70% of funding to local partners by 2020. The project is led by Jhpiego with the following partners: ICAP at Columbia University, Management Sciences for Health, Anova, BAO Systems, Johns Hopkins University Center for Public Health and Human Rights and Mann Global Health. RISE is currently active in several countries, including Côte d’Ivoire.
Performance Monitoring for Action Project (PMA)
This four-year project, funded by the Bill & Melinda Gates Foundation, builds on the PMA2020 project, which used innovative mobile technology to support low-cost, rapid-turnaround surveys monitoring key health and development indicators. PMA is enhancing this survey platform to generate high-quality data and ensure that governments, donors, managers and advocates use this data to make decisions regarding family planning programs. In addition to scaling up the survey platform for more widespread use, this project supports expanding it to include additional technical areas. Co-led by Jhpiego and the Bill & Melinda Gates Institute for Population and Reproductive Health, this project is operational in several African and Asian countries, including Côte d’Ivoire.
Improving Equitable Access to Human Papillomavirus Vaccination
This multi-country project—funded by Gavi, the Vaccine Alliance—targets several African countries. The overarching project goal is to support Ministries of Health with their national vaccination rollout, contributing to the elimination of cervical cancer in the targeted countries by achieving an equitable coverage rate of at least 70% among eligible girls by 2030. To reach this goal, Jhpiego is linking secondary prevention of cervical cancer (i.e., screening for cervical cancer) to primary prevention efforts (i.e., HPV vaccination)—and vice versa. To achieve equitable coverage, Jhpiego is using a multipronged approach to reach in- and out-of-school girls through activities such as school-based campaigns and community-based campaigns to reach out-of-school youth. This multipronged approach focuses on four areas: 1) community engagement with stakeholders and beneficiaries for social mobilization; 2) capacity development of health care providers; 3) vaccination integration into existing programs for adolescent/school health; and 4) ensuring high-quality HPV vaccination services.
Scale Up Cervical Cancer Elimination with Secondary Prevention Strategy (SUCCESS)
Unitaid is funding a consortium, led by Expertise France, that seeks to eliminate cervical cancer in Burkina Faso, Côte d’Ivoire, Guatemala and the Philippines through secondary prevention (i.e., detecting disease early to slow or halt its progress). The three-year SUCCESS project is designed to shift the countries from a largely opportunistic cervical cancer screening model to a systematic approach centered on innovations related to: 1) reinforced and simplified cervical cancer screening through the introduction of human papilloma virus (HPV) testing with self-collection sampling; 2) secondary prevention of cervical cancer including use of efficient methods for treatment of cervical precancerous lesions such as thermal ablation; and 3) intensified dissemination of information on cervical cancer and new preventive technologies. In so doing, SUCCESS aims to support countries to “leapfrog” to a state-of-the-art services model recommended by the World Health Organization. As the implementing partner of the consortium, Jhpiego is integrating and expanding cervical cancer prevention and treatment services into both new and existing platforms, relying on our established relationships with governments and stakeholders in all four countries. Through demand-generation and community engagement activities, the project plans to screen a total of 185,000 women, a significant proportion of whom will be women living with HIV.
Accelerating Uptake of Expanded Method Mix
Funded by the Bill & Melinda Gates Foundation, this program promotes access to family planning choices in West African countries by supporting the introduction and scale-up of subcutaneous depot-medroxyprogesterone acetate (DMPA-SC). DMPA-SC is an innovative injectable contraceptive—also known as Sayana® Press—that can dramatically expand access and choice for women. Jhpiego is enhancing ongoing efforts of the Access Collaborative by strengthening health systems to accelerate introduction and scale-up of DMPA-SC in several West African countries, including Côte d’Ivoire.